CFMS - ConforMIS Stock Price, News & Analysis

$3.28 0.04 (1.23 %)
(As of 11/23/2017 03:21 PM ET)
Previous Close$3.24
Today's Range$3.23 - $3.31
52-Week Range$3.03 - $9.47
Volume135,200 shs
Average Volume298,298 shs
Market Capitalization$148.56 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About ConforMIS (NASDAQ:CFMS)

ConforMIS logoConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.


Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:CFMS
CUSIPN/A

Debt

Debt-to-Equity Ratio0.52%
Current Ratio6.19%
Quick Ratio5.38%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$79.90 million
Price / Sales1.86
Cash FlowN/A
Price / CashN/A
Book Value$1.26 per share
Price / Book2.60

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPS($1.34)
Net Income$-57,580,000.00
Net Margins-72.70%
Return on Equity-76.88%
Return on Assets-51.42%

Miscellaneous

Employees387
Outstanding Shares45,290,000

Frequently Asked Questions for ConforMIS (NASDAQ:CFMS)

What is ConforMIS's stock symbol?

ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."

How were ConforMIS's earnings last quarter?

ConforMIS, Inc. (NASDAQ:CFMS) announced its quarterly earnings results on Wednesday, November, 1st. The medical instruments supplier reported ($0.29) EPS for the quarter, beating analysts' consensus estimates of ($0.32) by $0.03. The medical instruments supplier earned $18.40 million during the quarter, compared to analyst estimates of $17.55 million. ConforMIS had a negative return on equity of 76.88% and a negative net margin of 72.70%. The firm's revenue was down 1.3% on a year-over-year basis. During the same period in the prior year, the company earned ($0.31) earnings per share. View ConforMIS's Earnings History.

When will ConforMIS make its next earnings announcement?

ConforMIS is scheduled to release their next quarterly earnings announcement on Tuesday, February, 13th 2018. View Earnings Estimates for ConforMIS.

Where is ConforMIS's stock going? Where will ConforMIS's stock price be in 2017?

5 analysts have issued 12-month target prices for ConforMIS's shares. Their predictions range from $5.00 to $7.50. On average, they expect ConforMIS's stock price to reach $6.13 in the next year. View Analyst Ratings for ConforMIS.

Who are some of ConforMIS's key competitors?

Who are ConforMIS's key executives?

ConforMIS's management team includes the folowing people:

  • Kenneth Fallon III, Independent Chairman of the Board (Age 77)
  • Mark A. Augusti, President, Chief Executive Officer, Director (Age 51)
  • Paul S. Weiner, Chief Financial Officer (Age 53)
  • Dan Krupp, Senior Vice President - U.S. Sales
  • Daniel Steines M.D., Chief Technology Officer (Age 48)
  • David Cerveny, Chief Legal Officer and General Counsel (Age 50)
  • Philipp Lang M.D., Director (Age 54)
  • Bradley R. Langdale, Independent Director (Age 52)
  • Colm C. Lanigan, Independent Director (Age 51)
  • Richard J. Meelia, Independent Director (Age 68)

When did ConforMIS IPO?

(CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who owns ConforMIS stock?

ConforMIS's stock is owned by a number of of retail and institutional investors. Top institutional investors include Granite Investment Partners LLC (0.54%), Citadel Advisors LLC (0.25%) and Stonebridge Capital Management Inc. (0.08%). Company insiders that own ConforMIS stock include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner, Philipp Lang and Robert Law III. View Institutional Ownership Trends for ConforMIS.

Who bought ConforMIS stock? Who is buying ConforMIS stock?

ConforMIS's stock was bought by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, Citadel Advisors LLC and Stonebridge Capital Management Inc.. View Insider Buying and Selling for ConforMIS.

How do I buy ConforMIS stock?

Shares of ConforMIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ConforMIS's stock price today?

One share of ConforMIS stock can currently be purchased for approximately $3.28.

How big of a company is ConforMIS?

ConforMIS has a market capitalization of $148.56 million and generates $79.90 million in revenue each year. The medical instruments supplier earns $-57,580,000.00 in net income (profit) each year or ($1.34) on an earnings per share basis. ConforMIS employs 387 workers across the globe.

How can I contact ConforMIS?

ConforMIS's mailing address is 600 Technology Park Dr, BILLERICA, MA 01821-4154, United States. The medical instruments supplier can be reached via phone at +1-781-3459001 or via email at [email protected]formis.com.


MarketBeat Community Rating for ConforMIS (CFMS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  164 (Vote Outperform)
Underperform Votes:  143 (Vote Underperform)
Total Votes:  307
MarketBeat's community ratings are surveys of what our community members think about ConforMIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for ConforMIS (NASDAQ:CFMS)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 3 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $6.13 (86.74% upside)

Consensus Price Target History for ConforMIS (NASDAQ:CFMS)

Price Target History for ConforMIS (NASDAQ:CFMS)

Analysts' Ratings History for ConforMIS (NASDAQ:CFMS)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/2/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
8/4/2017Canaccord GenuityLower Price TargetHold$8.00 -> $6.00LowView Rating Details
8/4/2017Oppenheimer Holdings, Inc.Set Price TargetBuy$6.00HighView Rating Details
8/4/2017Deutsche Bank AGReiterated RatingBuy -> Hold$6.00 -> $5.00HighView Rating Details
5/16/2017B. RileyReiterated RatingBuy$7.50LowView Rating Details
11/4/2016J P Morgan Chase & CoReiterated RatingHold$11.00N/AView Rating Details
9/19/2016SunTrust Banks, Inc.Initiated CoverageBuy$14.00N/AView Rating Details
5/13/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
12/1/2015Sterne Agee CRTInitiated CoverageBuy$26.00N/AView Rating Details
(Data available from 11/23/2015 forward)

Earnings

Earnings History and Estimates Chart for ConforMIS (NASDAQ:CFMS)

Earnings by Quarter for ConforMIS (NASDAQ:CFMS)

Earnings History by Quarter for ConforMIS (NASDAQ CFMS)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/13/2018($0.28)N/AView Earnings Details
11/1/2017Q3 2017($0.32)($0.29)$17.55 million$18.40 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.36)($0.28)$19.34 million$18.50 millionViewListenView Earnings Details
5/10/2017Q1 2017($0.36)($0.40)$18.48 million$20.50 millionViewN/AView Earnings Details
2/15/2017Q416($0.30)($0.37)$21.37 million$21.70 millionViewListenView Earnings Details
11/3/2016Q316($0.36)($0.31)$18.27 million$18.60 millionViewListenView Earnings Details
8/8/2016Q216($0.35)($0.34)$18.02 million$19.30 millionViewListenView Earnings Details
5/12/2016Q116($0.38)($0.37)$19.23 million$20.30 millionViewListenView Earnings Details
2/11/2016Q415($0.41)($0.37)$17.23 million$19.10 millionViewListenView Earnings Details
11/2/2015Q3($0.38)($0.45)$13.51 million$13.90 millionViewN/AView Earnings Details
8/11/2015Q215($1.31)($2.51)$11.20 million$19.20 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ConforMIS (NASDAQ:CFMS)
2017 EPS Consensus Estimate: ($1.39)
2018 EPS Consensus Estimate: ($1.21)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.38)($0.36)($0.37)
Q2 20173($0.39)($0.35)($0.37)
Q3 20173($0.37)($0.29)($0.34)
Q4 20173($0.35)($0.28)($0.31)
Q1 20182($0.34)($0.29)($0.32)
Q2 20182($0.34)($0.28)($0.31)
Q3 20182($0.34)($0.23)($0.29)
Q4 20182($0.34)($0.26)($0.30)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for ConforMIS (NASDAQ:CFMS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for ConforMIS (NASDAQ CFMS)

Insider Ownership Percentage: 9.55%
Institutional Ownership Percentage: 36.41%
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)
Institutional Ownership by Quarter for ConforMIS (NASDAQ:CFMS)

Insider Trades by Quarter for ConforMIS (NASDAQ CFMS)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/15/2017Daniel SteinesCTOSell15,485$3.15$48,777.75View SEC Filing  
11/15/2017David CervenyInsiderSell16,392$3.17$51,962.64View SEC Filing  
11/15/2017Paul S WeinerCFOSell17,723$3.17$56,181.91View SEC Filing  
10/18/2017Daniel SteinesCTOSell907$3.51$3,183.57View SEC Filing  
10/18/2017Philipp LangDirectorSell1,839$3.53$6,491.67View SEC Filing  
6/20/2017Bradley LangdaleDirectorSell6,722$4.30$28,904.60View SEC Filing  
4/26/2017Daniel SteinesInsiderSell5,000$5.54$27,700.00View SEC Filing  
4/5/2017Daniel SteinesInsiderSell5,000$5.00$25,000.00View SEC Filing  
2/15/2017Philipp LangDirectorSell137,968$8.60$1,186,524.80View SEC Filing  
2/3/2017David CervenyInsiderSell3,569$8.59$30,657.71View SEC Filing  
2/3/2017Paul S WeinerCFOSell2,676$8.42$22,531.92View SEC Filing  
2/3/2017Philipp LangDirectorSell108,705$8.60$934,863.00View SEC Filing  
1/25/2017Philipp LangDirectorSell108,985$8.60$937,271.00View SEC Filing  
1/23/2017Philipp LangDirectorSell9,681$8.60$83,256.60View SEC Filing  
1/13/2017Philipp LangDirectorSell37,275$8.60$320,565.00View SEC Filing  
1/11/2017Philipp LangDirectorSell2,800$8.62$24,136.00View SEC Filing  
1/10/2017Philipp LangDirectorSell83,909$8.64$724,973.76View SEC Filing  
1/9/2017Philipp LangDirectorSell6,200$8.65$53,630.00View SEC Filing  
1/5/2017Philipp LangDirectorSell400$8.60$3,440.00View SEC Filing  
1/3/2017Philipp LangDirectorSell74,876$8.00$599,008.00View SEC Filing  
12/30/2016Philipp LangDirectorSell168,734$8.25$1,392,055.50View SEC Filing  
12/28/2016Philipp LangDirectorSell58,547$8.26$483,598.22View SEC Filing  
12/27/2016Philipp LangDirectorSell42,086$8.57$360,677.02View SEC Filing  
12/23/2016Philipp LangDirectorSell30,647$8.62$264,177.14View SEC Filing  
10/17/2016Daniel SteinesInsiderSell889$8.64$7,680.96View SEC Filing  
10/17/2016Paul S WeinerCFOSell884$8.60$7,602.40View SEC Filing  
10/12/2016Daniel SteinesInsiderSell10,000$9.66$96,600.00View SEC Filing  
10/5/2016Philipp LangCEOSell53,860$10.19$548,833.40View SEC Filing  
10/4/2016Philipp LangCEOSell400$10.00$4,000.00View SEC Filing  
10/3/2016Daniel SteinesCTOSell10,000$10.03$100,300.00View SEC Filing  
10/3/2016Philipp LangCEOSell10,410$10.03$104,412.30View SEC Filing  
9/16/2016Daniel SteinesInsiderSell30,000$9.09$272,700.00View SEC Filing  
8/17/2016Kenneth P Fallon IIIDirectorSell4,000$8.44$33,760.00View SEC Filing  
5/17/2016Robert Law IIISVPBuy1,600$6.20$9,920.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ConforMIS (NASDAQ CFMS)

Source:
DateHeadline
ConforMIS (CFMS) & Its Competitors Head to Head ContrastConforMIS (CFMS) & Its Competitors Head to Head Contrast
www.americanbankingnews.com - November 21 at 9:24 PM
Analyzing ConforMIS (CFMS) and Its PeersAnalyzing ConforMIS (CFMS) and Its Peers
www.americanbankingnews.com - November 19 at 9:26 PM
Insider Selling: ConforMIS, Inc. (CFMS) CTO Sells 15,485 Shares of StockInsider Selling: ConforMIS, Inc. (CFMS) CTO Sells 15,485 Shares of Stock
www.americanbankingnews.com - November 16 at 9:24 PM
ConforMIS, Inc. (CFMS) CFO Paul S. Weiner Sells 17,723 SharesConforMIS, Inc. (CFMS) CFO Paul S. Weiner Sells 17,723 Shares
www.americanbankingnews.com - November 16 at 9:22 PM
ConforMIS, Inc. (CFMS) Insider Sells $51,962.64 in StockConforMIS, Inc. (CFMS) Insider Sells $51,962.64 in Stock
www.americanbankingnews.com - November 16 at 9:22 PM
ConforMIS (CFMS) and Its Peers Head-To-Head AnalysisConforMIS (CFMS) and Its Peers Head-To-Head Analysis
www.americanbankingnews.com - November 10 at 1:16 AM
ETFs with exposure to ConforMIS, Inc. : November 8, 2017ETFs with exposure to ConforMIS, Inc. : November 8, 2017
finance.yahoo.com - November 8 at 8:41 PM
Contrasting ConforMIS (CFMS) & OrthoPediatrics Corp. (KIDS)Contrasting ConforMIS (CFMS) & OrthoPediatrics Corp. (KIDS)
www.americanbankingnews.com - November 7 at 3:28 AM
FY2017 Earnings Forecast for ConforMIS, Inc. Issued By Oppenheimer Holdings (CFMS)FY2017 Earnings Forecast for ConforMIS, Inc. Issued By Oppenheimer Holdings (CFMS)
www.americanbankingnews.com - November 6 at 6:38 AM
ConforMIS, Inc. (CFMS) Given Consensus Rating of "Hold" by BrokeragesConforMIS, Inc. (CFMS) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 5 at 7:38 AM
Edited Transcript of CFMS earnings conference call or presentation 1-Nov-17 8:30pm GMTEdited Transcript of CFMS earnings conference call or presentation 1-Nov-17 8:30pm GMT
finance.yahoo.com - November 2 at 5:53 PM
ConforMIS Reports Third Quarter 2017 Financial Results - GlobeNewswire (press release)ConforMIS Reports Third Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - November 1 at 10:54 PM
ConforMIS reports 3Q lossConforMIS reports 3Q loss
finance.yahoo.com - November 1 at 10:54 PM
Is It Too Late To Buy ConforMIS Inc (CFMS)?Is It Too Late To Buy ConforMIS Inc (CFMS)?
finance.yahoo.com - November 1 at 5:52 PM
ConforMIS Inc to Host Earnings CallConforMIS Inc to Host Earnings Call
finance.yahoo.com - November 1 at 5:52 PM
ConforMIS Reports Third Quarter 2017 Financial ResultsConforMIS Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 1 at 5:52 PM
ConforMIS, Inc. (CFMS) Announces  Earnings Results, Beats Expectations By $0.03 EPSConforMIS, Inc. (CFMS) Announces Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - November 1 at 5:29 PM
ConforMIS, Inc. (CFMS) Stock Rating Lowered by Zacks Investment ResearchConforMIS, Inc. (CFMS) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - October 31 at 8:36 PM
ETFs with exposure to ConforMIS, Inc. : October 25, 2017ETFs with exposure to ConforMIS, Inc. : October 25, 2017
finance.yahoo.com - October 25 at 6:38 PM
ConforMIS, Inc. (CFMS) to Release Earnings on WednesdayConforMIS, Inc. (CFMS) to Release Earnings on Wednesday
www.americanbankingnews.com - October 25 at 6:52 AM
$17.69 Million in Sales Expected for ConforMIS, Inc. (CFMS) This Quarter$17.69 Million in Sales Expected for ConforMIS, Inc. (CFMS) This Quarter
www.americanbankingnews.com - October 18 at 1:48 AM
Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee ImplantsLeader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants
finance.yahoo.com - October 16 at 5:52 PM
ETFs with exposure to ConforMIS, Inc. : October 13, 2017ETFs with exposure to ConforMIS, Inc. : October 13, 2017
finance.yahoo.com - October 13 at 5:44 PM
ConforMIS to Host Third Quarter 2017 Financial Results Conference Call and Webcast on November 1, 2017 - GlobeNewswire (press release)ConforMIS to Host Third Quarter 2017 Financial Results Conference Call and Webcast on November 1, 2017 - GlobeNewswire (press release)
globenewswire.com - October 12 at 10:54 PM
ConforMIS to Host Third Quarter 2017 Financial Results Conference Call and Webcast on November 1, 2017ConforMIS to Host Third Quarter 2017 Financial Results Conference Call and Webcast on November 1, 2017
finance.yahoo.com - October 12 at 5:54 PM
ConforMIS, Inc. (CFMS) Given Average Recommendation of "Hold" by AnalystsConforMIS, Inc. (CFMS) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - October 11 at 8:48 AM
5 MedTech Stocks to Buy Before Q3 Earnings5 MedTech Stocks to Buy Before Q3 Earnings
finance.yahoo.com - October 5 at 4:11 PM
 Brokerages Anticipate ConforMIS, Inc. (CFMS) Will Post Earnings of -$0.31 Per Share Brokerages Anticipate ConforMIS, Inc. (CFMS) Will Post Earnings of -$0.31 Per Share
www.americanbankingnews.com - September 28 at 4:28 AM
ETFs with exposure to ConforMIS, Inc. : September 19, 2017ETFs with exposure to ConforMIS, Inc. : September 19, 2017
finance.yahoo.com - September 19 at 10:13 PM
ConforMIS, Inc. :CFMS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017ConforMIS, Inc. :CFMS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 3:38 PM
ConforMIS, Inc. (CFMS) Receives Average Recommendation of "Hold" from AnalystsConforMIS, Inc. (CFMS) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 16 at 8:34 AM
Head to Head Review: ConforMIS (CFMS) versus Stryker Corporation (SYK)Head to Head Review: ConforMIS (CFMS) versus Stryker Corporation (SYK)
www.americanbankingnews.com - September 10 at 6:06 AM
Comparing Stryker Corporation (SYK) and ConforMIS (CFMS)Comparing Stryker Corporation (SYK) and ConforMIS (CFMS)
www.americanbankingnews.com - September 4 at 12:24 AM
Digital Impulse Ranks No. 3,830 on the 2017 Inc. 5000 with Three-Year Sales Growth of 76%Digital Impulse Ranks No. 3,830 on the 2017 Inc. 5000 with Three-Year Sales Growth of 76%
www.bizjournals.com - August 23 at 5:25 PM
ConforMIS, Inc. (CFMS) Receives Average Recommendation of "Buy" from AnalystsConforMIS, Inc. (CFMS) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - August 22 at 8:34 AM
Financial Contrast: Obalon Therptcs (OBLN) vs. ConforMIS (CFMS)Financial Contrast: Obalon Therptcs (OBLN) vs. ConforMIS (CFMS)
www.americanbankingnews.com - August 18 at 6:22 AM
Head to Head Comparison: Endologix (ELGX) & ConforMIS (CFMS)Head to Head Comparison: Endologix (ELGX) & ConforMIS (CFMS)
www.americanbankingnews.com - August 13 at 12:40 PM
ConforMIS Inc (CFMS) Reports Acquisition of Machine & Polishing Assets from Broad Peak Manufacturing for $6.5MConforMIS Inc (CFMS) Reports Acquisition of Machine & Polishing Assets from Broad Peak Manufacturing for $6.5M
www.streetinsider.com - August 10 at 6:19 PM
Brokers Set Expectations for ConforMIS, Inc.s Q3 2017 Earnings (NASDAQ:CFMS)Brokers Set Expectations for ConforMIS, Inc.'s Q3 2017 Earnings (NASDAQ:CFMS)
www.americanbankingnews.com - August 10 at 12:04 PM
ConforMIS Inc (CFMS) Reports Acquisition of Machine & Polishing ... - StreetInsider.comConforMIS Inc (CFMS) Reports Acquisition of Machine & Polishing ... - StreetInsider.com
www.streetinsider.com - August 9 at 5:18 PM
ConforMIS Acquires Machining and Polishing Assets from Broad Peak ManufacturingConforMIS Acquires Machining and Polishing Assets from Broad Peak Manufacturing
finance.yahoo.com - August 9 at 5:18 PM
Uroplasty (UPI) & ConforMIS (CFMS) Critical ReviewUroplasty (UPI) & ConforMIS (CFMS) Critical Review
www.americanbankingnews.com - August 9 at 12:24 PM
ConforMIS, Inc. (NASDAQ:CFMS) Rating Reiterated by Deutsche Bank AGConforMIS, Inc. (NASDAQ:CFMS) Rating Reiterated by Deutsche Bank AG
www.americanbankingnews.com - August 6 at 9:06 PM
Oppenheimer Holdings, Inc. Reiterates $6.00 Price Target for ConforMIS, Inc. (NASDAQ:CFMS)Oppenheimer Holdings, Inc. Reiterates $6.00 Price Target for ConforMIS, Inc. (NASDAQ:CFMS)
www.americanbankingnews.com - August 6 at 7:08 PM
ConforMIS, Inc. (NASDAQ:CFMS) Price Target Lowered to $6.00 at Canaccord GenuityConforMIS, Inc. (NASDAQ:CFMS) Price Target Lowered to $6.00 at Canaccord Genuity
www.americanbankingnews.com - August 6 at 3:18 PM
ConforMIS (CFMS) vs. Second Sight Medical Products (EYES) Head to Head ReviewConforMIS (CFMS) vs. Second Sight Medical Products (EYES) Head to Head Review
www.americanbankingnews.com - August 6 at 8:06 AM
ConforMIS, Inc. (NASDAQ:CFMS) Expected to Announce Quarterly Sales of $19.76 MillionConforMIS, Inc. (NASDAQ:CFMS) Expected to Announce Quarterly Sales of $19.76 Million
www.americanbankingnews.com - August 5 at 7:09 AM
Pre-Open Movers 08/04: (YELP) (GPRO) (ANET) Higher; (EFII) (AAOI) (PI) Lower (more...)Pre-Open Movers 08/04: (YELP) (GPRO) (ANET) Higher; (EFII) (AAOI) (PI) Lower (more...)
www.streetinsider.com - August 4 at 10:24 PM
ConforMIS, Inc. (CFMS) Announces Quarterly  Earnings Results, Beats Estimates By $0.08 EPSConforMIS, Inc. (CFMS) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS
www.americanbankingnews.com - August 4 at 7:30 PM
After-Hours Stock Movers 08/03: (YELP) (WTW) (ANET) Higher; (AAOI) (PI) (SYNA) Lower (more...)After-Hours Stock Movers 08/03: (YELP) (WTW) (ANET) Higher; (AAOI) (PI) (SYNA) Lower (more...)
www.streetinsider.com - August 4 at 5:23 PM

Social Media

Financials

Chart

ConforMIS (NASDAQ CFMS) Chart for Thursday, November, 23, 2017
Loading chart…

This page was last updated on 11/23/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.